| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.2M | — | +280.8% |
| Cost of Revenue | $2.4M | — | +417.3% |
| Gross Profit | -$189K | — | -258.0% |
| R&D Expense | $10K | — | -89.8% |
| SG&A Expense | $3.6M | — | -0.9% |
| Operating Income | -$3.8M | — | +72.5% |
| Pre-tax Income | -$4.0M | — | +71.6% |
| Income Tax | $0 | — | — |
| Net Income | -$4.0M | — | +71.6% |
| EPS (Basic) | -$0.31 | — | +51.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.0M | +461.0% | +853.1% |
| Inventory | $0 | — | -100.0% |
| Current Assets | $6.8M | +94.3% | -66.3% |
| Total Assets | $11.2M | +139.7% | -55.0% |
| Current Liabilities | $18.3M | +37.8% | +16.8% |
| Long-term Debt | $4.5M | +834.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.3M | — | +20.8% |
| Capital Expenditures | $1.5M | — | +762.9% |
| Investing Cash Flow | -$1.5M | — | -762.9% |
| Financing Cash Flow | $6.5M | — | +144.8% |
| Free Cash Flow | -$4.9M | — | -10.8% |
| -0.7% |
| Total Liabilities | $19.4M | +42.4% | +23.6% |
| Stockholders' Equity | -$8.2M | +8.4% | -189.2% |